Innophos Acknowledges Receipt Of Investor Letter

CRANBURY, N.J., Oct. 7, 2014 /PRNewswire/ -- Innophos Holdings, Inc. IPHS, today announced that it had received a letter from FrontFour Capital Group LLC. 

Innophos is committed to executing a business strategy aligned with the best interests of the Company and all of its shareholders.  The Company regularly engages in open and transparent dialogue with investors and will always consider constructive input from shareholders that helps drive long-term shareholder value. 

About Innophos Holdings, Inc.

Innophos is a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets.  Innophos combines more than a century of experience in specialty phosphate manufacturing with a growing capability in a broad range of other specialty ingredients to supply a product range produced to stringent regulatory manufacturing standards and the quality demanded by customers worldwide.  Innophos is continually developing new and innovative specialty ingredients addressing specific customer applications and supports these high-value products with industry-leading technical service.  Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Ogden, UT; North Salt Lake, UT; Salt Lake City, UT; Paterson, NJ; Green Pond, SC; Port Maitland, ON (Canada); Taicang (China); Coatzacoalcos, Veracruz and San Jose de Iturbide (Mission Hills), Guanajuato (Mexico). For more information please visit www.innophos.com. 'IPHS-G'

SOURCE Innophos Holdings, Inc.